Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT04577404 · COMPLETED

Trial details

NCT number: NCT04577404
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2020-10-29
Primary completion: 2023-08-09
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.